HDAC9 and colorectal carcinoma: With individual and combination treatments, there was reduced proliferation of SW480, HT29, and HCT116 cells (Fig. 1Di-iii), the effect was pronounced in SW480 and HT29 CRC cells (Fig. 1Di-ii), which exhibit no genetic alterations in JAK/HDAC target molecules (see Table S1).